 |
TABLES OF RULES 2006
NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS
| |
Mutations associated to resistance |
Mutations associated to « possible resistance » |
ZDV
|
T215Y/F
 |
At least 3 mutations among : M41L, D67N, K70R, L210W, T215A/C/D/E/G/H/I/L/N/S/V, K219Q/E [1, 2, 3, 4]
|
Q151M
Insertion at codon 69
|
T215A/C/D/E/G/H/I/L/N/S/V [1, 2, 3, 4] |
3TC/FTC
|
M184V/I
Insertion at codon 69
|
K65R [11, 12, 16]
Q151M
|
ddI
|
 |
At least a score of + 2 among: M41L + T69D + L74V + T215Y/F + K219Q/E K70R M184 V/I [5, 14, 15, 17, 18]
|
 |
L74V without any mutations among M41L, T69D, K70R, M184 V/I, T215Y/F, K219Q/E [19] |
Q151M
Insertion at codon 69
|
K65R [11, 12]
|
d4T
|
V75M/S/A/T
T215Y/F [6]
 |
At least 3 mutations among : M41L, D67N, K70R, L210W, T215A/C/D/E/G/H/I/L/N/S/V, K219Q/E [4, 7, 14, 15]
|
Q151M
Insertion at codon 69
|
T215A/C/D/E/G/H/I/L/N/S/V [4, 7] |
ABC
|
 |
At least 5 mutations among : M41L, D67N, L74V, M184V/I, L210W, T215Y/F [8, 19]
|
K65R and L74V and Y115F and M184V/I
Q151M
Insertion at codon 69
|
 |
4 mutations among : M41L, D67N, L74V, M184V/I, L210W, T215Y/F [8, 19]
|
K65R [9, 11, 12]
|
TDF
|
 |
At least 6 mutations among: M41L, E44D, D67N, T69D/N/S, L74V, L210W, T215Y/F [13, 20]
|
K65R [9, 10, 11, 12]
Insertion at codon 69
|
 |
3, 4 or 5 mutations among: : M41L, E44D, D67N, T69D/N/S, L74V, L210W, T215Y/F [13] |
K70E [21, 22, 23] |
TAMs = M41L, D67N, K70R, L210W, T215Y/F, K219Q/E
ZDV: zidovudine, 3TC: lamivudine, FTC: emtricitabine, ddI: didanosine, d4T: stavudine, ABC: abacavir, TDF: tenofovir
Mutations associated to antiretroviral regimen but with uncertain signification:
E44A, D67E/G, T69A, L74I, K219N/R
References |
 |